How Many AI-Enabled Devices Has FDA Authorized? FDA's Figure and Our Count
Sooner or later a slide needs the line "FDA has authorized ___ AI-enabled medical devices," and someone has to decide which number goes in the blank.
FDA's own answer is that it has authorized more than 1,600 AI-enabled medical devices as of September 2026. On the page that holds the list, FDA also says that "the list is not a comprehensive resource of AI-enabled medical devices." So there is an official headline figure, but it is not an exhaustive count.
RA Craft Database counts the records it holds that are confirmed as AI/ML-enabled, mainly through FDA's AI-enabled device list. That tally is 1,649 (records held in RA Craft Database, decisions from January 2015 through September 30, 2026, tallied October 9, 2026; not reconciled with FDA's own figures). Confirmation covers only part of the records we hold, so this is not a complete count either.
A device named "AI" whose classification never says so
Take DEN250028, the DeepView AI® System, granted De Novo authorization in May 2026. Its product code is SHY, its regulation is 21 CFR 878.1840, and its classification name is "software-aided adjunctive diagnostic device for use by healthcare providers in skin wound assessment." "21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.
The device name includes "AI"; the classification name does not. Classification names describe what a device is for, not whether it uses AI, and product codes follow the classification. That is why AI devices cannot be counted by product code or classification name. Each record has to be checked, and the result depends on what the check relies on. DEN250028 carries this site's AI/ML flag.
How the two counts differ
Both counts are by authorization record, not by distinct commercial product. If a product line was authorized through several submissions, each one is counted.
| FDA's list | RA Craft Database | |
|---|---|---|
| Universe | AI-enabled devices FDA has authorized | 510(k), De Novo and PMA records from 2015 onward held on this site |
| How a device is identified | Primarily by AI-related terms in the summary descriptions of the marketing authorization document and/or the device's classification | AI/ML use confirmed, mainly through FDA's AI-enabled device list |
| Completeness | FDA states it is "not a comprehensive resource" | Confirmation covers only part of the records |
| Count | More than 1,600 (FDA's figure, as of September 2026) | 1,649 (decisions through September 30, 2026) |
FDA adds a caveat about its own method: the summaries "are not all inclusive and do not include most of the information that may be submitted in an application." A device whose summary and classification never use an AI term can be missing from the list even if it uses AI. Our tally has its own limits. Because it relies mainly on FDA's list, a device missing from the list is included only if it was confirmed some other way; recent months have not been reviewed yet; and coverage starts with 2015 decisions. That is why the two figures are close.
In our view, both figures are best read as "at least this many." Whichever you use, put its source and date in the footnote.
By year and pathway
Our confirmed AI/ML records by decision year and pathway. The PMA column includes supplements.
| Year | 510(k) | De Novo | PMA | Total |
|---|---|---|---|---|
| 2015 | 6 | 0 | 0 | 6 |
| 2016 | 17 | 0 | 1 | 18 |
| 2017 | 23 | 2 | 2 | 27 |
| 2018 | 58 | 7 | 0 | 65 |
| 2019 | 80 | 0 | 0 | 80 |
| 2020 | 113 | 1 | 0 | 114 |
| 2021 | 122 | 7 | 1 | 130 |
| 2022 | 160 | 1 | 1 | 162 |
| 2023 | 219 | 6 | 1 | 226 |
| 2024 | 226 | 9 | 1 | 236 |
| 2025 | 329 | 2 | 2 | 333 |
| 2026 (Jan–Sep) | 247 | 3 | 2 | 252 |
Records held in RA Craft Database, decisions from January 2015 through September 30, 2026.
The count grew from 6 in 2015 to 333 in 2025. Of the 1,397 confirmed records from 2015 through 2025, 1,353 (about 97 percent) were 510(k) clearances, 35 were De Novo grants and 9 were PMAs (7 original, 2 supplements). The 2026 figure of 252 covers January to September. Only about one in ten 2026 records each month has been reviewed for AI/ML so far, so it should not be compared with earlier years. Earlier years can also rise as the review continues.
By review panel
Of the devices on FDA's AI-enabled device list (as saved on July 26, 2026), 1,524 are held on this site. Grouped by the lead review panel the list gives, Radiology accounts for 1,164, about 76 percent, followed by Cardiovascular (147), Neurology (70), Anesthesiology (26) and Gastroenterology-Urology (25). For 2021 through 2025 alone, Radiology holds 863 of 1,086, about 79 percent. Devices FDA added after the list was saved are not included.
The counts show that AI-enabled devices cluster in imaging; they do not explain why. If your own panel has few entries, that does not mean predicates are scarce, so check the records under your product code.
Our view: in the confirmed records, 510(k) is the main route
A large 510(k) share means that substantial equivalence to a predicate is a common regulatory route for these AI/ML devices. It does not mean the technology is not new. A device with different technological characteristics can still be cleared through a 510(k) if those differences raise no different questions of safety and effectiveness and the device is shown to be as safe and effective as the predicate.
When there is no predicate, a device may be granted De Novo, which establishes a new classification and product code. Product code QNP, for gastrointestinal lesion detection software, was created when GI Genius (DEN200055) was granted De Novo on April 9, 2021. Since then, devices such as GI Genius (K241887), SKOUT system (K253664) and EW10-EC02 Endoscopy Support Program (K260567) have been cleared under QNP through 510(k). Of these, SKOUT system (K253664) carries this site's AI/ML flag. SHY, from the opening example, also came from a De Novo.
If you are planning an AI device, find the product code closest to yours and check how that classification was established. If it originated in a De Novo, reading that record and then the 510(k)s that followed shows how the category has developed and what FDA has asked for along the way. Updating an algorithm after authorization under a Predetermined Change Control Plan (PCCP) is covered in a separate article.
Three questions to ask of any AI-device count
When someone quotes a number of "FDA AI devices," in a pitch deck, a news story or this article, it helps to ask whose definition it uses, what date it reflects, and which pathways and years it covers. FDA's list, this site's confirmed records, and a count built from press releases or product names will all give different answers. A figure means something only with those answers attached.
Find AI/ML records on this site
On Search, tick AI/ML and narrow by your product code. Star (☆) the records you want, then tick "Compare" on them in My Workspace and press "N selected for comparison." The Indications for Use line up verbatim, which gives you the material for working out what is the same as a predicate and what is different.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles